Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-046347

Chief Medical Officer bought 1,768 shares at $4.81 ($8,504)

From the SEC's structured data for this filing

Trades in this filing

Levy Howard · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-10 Purchase : show line 1 in the form +1,768 $4.81 $8,504 4,268 D
Open-market purchases · 1,768 sh · avg $4.81 · $8,504
Loading xslF345X03/doc4.xml…